I CON LABS is one of our more recent ventures as we break into medical diagnostics and personalized medicine, including toxicology and pharmacology. Expanding to diagnostics has given our physicians increased access to customizable treatment for their patients while at the same time increasing their cash flows. With the use of cutting edge technology, physicians can precisely and accurately target ailments with customized treatment to minimize side effects and take out the guess work. We have been successful in structuring investments within this division in a way that produces income from both the diagnostics side and the pharmacy side, doubling the investors’ potential returns and maximizing the efficiency of each dollar.

  • Toxicology
  • Pathology
  • DNA Testing
  • Molecular Diagnostics
  • Pharmacology
  • Pharmacogenetics/Pharmacokinetics